# Thrombin+calcium chloride+aprotinin+protein clotta

## Tisseel solution for sealant 4mL/set

| TAH Drug Code      | [ETIS4](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ETIS4)                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Adjunctive therapy for hemostasis when standard surgical techniques are insufficient. Indicated for fixation of surgical mesh in hernia repair as an alternative or supplement to sutures or staples.                                                                                                                                                                                                                                                                                                               |
| Dosing             | 2mL of TISSEEL， which means 1mL TISSEEL and 1mL of thrombin solution， could cover at least 10cm2， depending on surgery type， wound size and frequency.                                                                                                                                                                                                                                                                                                                                                          |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Contraindications  | This product must not be used alone for the treatment of massive and rapid arterial or venous bleeding. This product is not intended as a substitute for skin sutures in the closure of surgical wounds. This product must not be used intravascularly， as intravascular use may lead to thromboembolic events that can be life-threatening. This product is not suitable for individuals with known hypersensitivity to any of its active ingredients or excipients.                                              |
| Adverse Effects    | May be related to aprotinin contained in some products. Frequency may vary by product. 1% to 10%: Cardiovascular: Bradycardia (?10%) Central nervous system: Fever (6%) Dermatologic: Pruritus Gastrointestinal: Abdominal distension (4%) Hematologic & oncologic: Hematoma (Facial rhytidectomy: 1% to 4%)， hemorrhage (internal， postprocedural; 2%)， increased serum fibrinogen (2%) Immunologic: Antibody development (1% to 2%) Local: Skin graft failure (3%) Respiratory: Pulmonary embolism (<1% to 3%) |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| More Info          | [UpToDate](https://www.uptodate.com/contents/thrombin+calcium-chloride+aprotinin+protein-clotta-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                   |

